Bio-Chem Fluidics introduces redesigned pinch valve series
Bio-Chem Fluidics" newly redesigned solenoid operated pinch valves provide more effective control of flow paths for fluid handling systems.
The new design eliminates sharp edges, with smooth contours that allow easier insertion and removal of tubing without snares. An integrated insert provides both positive tube retention and confirmation of correct tubing size. Manual push-button override is available as an option.
The valve's new design also includes a valve body constructed from Luran and a plunger composed of Ryton. These materials are resistant to most common cleaning solutions and easily meet Bio-Chem Fluidics" two million cycle operation standard.
Bio-Chem Fluidics is a world leading manufacturer of inert, miniature fluid handling components. Under its Bio-Chem Valve brand it offers complete fluid system solutions for a wide range of industries including analytical chemistry, clinical diagnostics and medical device manufacture. The company's design and prototyping expertise also enables it to offer simple modifications of standard products as well as completely customised designs.
You may also like
Manufacturing
Lonza appoints Hans Trees as Global Head of Communications
Read moreHans Trees will join Lonza as Global Head of Communications, Senior Vice President and Member of the Extended Executive Committee, effective 1 September 2026. Hans combines deep industry experience with a strong track record in stakeholder engagement, most recently serving as Global Head of External Engagement at Roche
Trending Articles
You may also like
Manufacturing
Lonza appoints Hans Trees as Global Head of Communications
Hans Trees will join Lonza as Global Head of Communications, Senior Vice President and Member of the Extended Executive Committee, effective 1 September 2026. Hans combines deep industry experience with a strong track record in stakeholder engagement, most recently serving as Global Head of External Engagement at Roche
Manufacturing
AlzeCure licenses Alzheimer’s candidate ACD680 to Lilly in deal worth up to $1bn
AlzeCure Pharma has entered a global licensing and collaboration agreement with Eli Lilly for its Alzheimer's disease candidate ACD680, securing a $10m upfront payment and potential milestone payments exceeding $1bn
Manufacturing
Safety in pharmaceutical manufacturing: why a trusted partner makes all the difference
By taking a three-tiered approach to protecting patients and personnel and ensuring plant compliance, GEA adopts a consultative approach to helping its customers navigate the responsibilities of pharmaceutical manufacturing safety with confidence
Manufacturing
Aragen to manufacture Renaissance Pharma’s FDA Fast Track mAb as part of ongoing strategic collaboration
CRDMO successfully scaled and transferred Renaissance Pharma’s lead candidate, Daretabart a humanised monoclonal antibody targeting GD2 for high-risk neuroblastoma, in just 9 months
Manufacturing
Next expansion milestone achieved: SCHOTT Pharma opens production facility in Serbia to strengthen competitiveness in Europe
After a double-digit million euro investment and less than 1.5 years of construction, SCHOTT Pharma opens new manufacturing site in Jagodina, Serbia. Production capacity to meet European market demand for pharmaceutical ampoules. Facility brings around 180 new jobs to the region